Literature DB >> 23807810

Alterations in sulfur amino acid metabolism in mice treated with silymarin: a novel mechanism of its action involved in enhancement of the antioxidant defense in liver.

Do Young Kwon1, Young Suk Jung, Sun Ju Kim, Young Soon Kim, Dal Woong Choi, Young Chul Kim.   

Abstract

It has been known that silymarin exhibits protective activity against oxidative liver injury induced by various hepatotoxicants, but the underlying mechanism of its beneficial action remains unclear. We determined the alterations in sulfur-containing amino acid metabolism induced by silymarin in association with its effects on the antioxidant capacity of liver. Male mice were treated with silymarin (100 or 200 mg/kg, p. o.) every 12 h for a total of 3 doses, and sacrificed 6 h after the final dosing. The hepatic methionine level was increased, but the activity and protein expression of methionine adenosyltransferase were decreased by silymarin in a dose-dependent manner. S-Adenosylmethionine or homocysteine concentration was not changed, whereas the sulfur-containing metabolites generated from homocysteine in the transsulfuration pathway including cystathionine, cysteine, and glutathione were increased significantly. Cystathionine β-synthase was induced, but cysteine dioxygenase was downregulated, both of which would contribute to the elevation of cysteine and its product, glutathione, in liver. Oxygen radical scavenging capacity of liver cytosol against peroxyl radical and peroxynitrite was increased, and also hepatic lipid peroxidation was diminished in the silymarin-treated mice. Taken together, the results demonstrate that silymarin enhances hepatic glutathione generation by elevating cysteine availability via an increment in cysteine synthesis and an inhibition of its catabolism to taurine, which may subsequently contribute to the antioxidant defense of liver. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807810     DOI: 10.1055/s-0032-1328704

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

Review 1.  Hepatoprotective effect of silymarin.

Authors:  Nancy Vargas-Mendoza; Eduardo Madrigal-Santillán; Angel Morales-González; Jaime Esquivel-Soto; Cesar Esquivel-Chirino; Manuel García-Luna Y González-Rubio; Juan A Gayosso-de-Lucio; José A Morales-González
Journal:  World J Hepatol       Date:  2014-03-27

Review 2.  Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.

Authors:  Han Ah Lee; Young Chang; Pil Soo Sung; Eileen L Yoon; Hye Won Lee; Jeong-Ju Yoo; Young-Sun Lee; Jihyun An; Do Seon Song; Young Youn Cho; Seung Up Kim; Yoon Jun Kim
Journal:  Clin Mol Hepatol       Date:  2022-07-01

3.  Thioredoxin regulates human mercaptopyruvate sulfurtransferase at physiologically-relevant concentrations.

Authors:  Pramod Kumar Yadav; Victor Vitvitsky; Sebastián Carballal; Javier Seravalli; Ruma Banerjee
Journal:  J Biol Chem       Date:  2020-03-16       Impact factor: 5.157

4.  Organization of the human mitochondrial hydrogen sulfide oxidation pathway.

Authors:  Marouane Libiad; Pramod Kumar Yadav; Victor Vitvitsky; Michael Martinov; Ruma Banerjee
Journal:  J Biol Chem       Date:  2014-09-15       Impact factor: 5.157

Review 5.  Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance.

Authors:  Ján Lehotský; Barbara Tothová; Maria Kovalská; Dušan Dobrota; Anna Beňová; Dagmar Kalenská; Peter Kaplán
Journal:  Front Neurosci       Date:  2016-11-23       Impact factor: 4.677

6.  Methionine Partially Replaced by Methionyl-Methionine Dipeptide Improves Reproductive Performance over Methionine Alone in Methionine-Deficient Mice.

Authors:  Qiong Chen; Wenting Dai; Yalu Sun; Fengqi Zhao; Jianxin Liu; Hongyun Liu
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

7.  Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.

Authors:  Anton Gillessen; Hartmut H-J Schmidt
Journal:  Adv Ther       Date:  2020-02-17       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.